A CITF-funded study, published in preprint and not yet peer-reviewed, found that the reporting of SARS-CoV-2 seroepidemiologic studies needs improvement, particularly in providing adequately detailed information about laboratory methods. Researchers showed that there was a median adherence to reporting items of 48% per study, as evaluated via the Reporting of Seroepidemiologic studies—SARS-CoV-2 (ROSES-S) guideline.